Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-011769

Atara Biotherapeutics, Inc. · ATRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Feb 15, 2017
Accepted (ET)
Feb 16, 2017 · 8:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604464

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 15, 2017M1,548$0.00A102,558D
Common StockF1Feb 15, 2017M817$0.00A103,375D
Common StockFeb 16, 2017S1,183$16.10D102,192D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF3,F4,F5—Feb 15, 2017M1,548D——Common Stock1,5486,194D
Restricted Stock UnitsF3,F6,F7—Feb 15, 2017M817D——Common Stock8173,814D

Explanation of responses